TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
NeuroGyn Norr AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
61
|
131
|
190 |
| Financial expenses |
13
|
10
|
14 |
| Earnings before taxes |
-30
|
-31
|
7 |
| EBITDA |
-17
|
-19
|
21 |
| Total assets |
60
|
88
|
130 |
| Current assets |
47
|
71
|
110 |
| Current liabilities |
45
|
67
|
63 |
| Equity capital |
15
|
22
|
65 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
25.0%
|
25.0%
|
50.0% |
| Turnover per employee |
61
|
66
|
95 |
| Profit as a percentage of turnover |
-49.2%
|
-23.7%
|
3.7% |
| Return on assets (ROA) |
-28.3%
|
-23.9%
|
16.2% |
| Current ratio |
104.4%
|
106.0%
|
174.6% |
| Return on equity (ROE) |
-200%
|
-140.9%
|
10.8% |
| Change turnover |
-70
|
-44
|
-17 |
| Change turnover % |
-53%
|
-25%
|
-8% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.